Cargando…

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α

Doxorubicin (DOX)-based chemotherapy is widely used to treat malignant tumors; however, the cardiotoxicity induced by DOX restricts its clinical usage. A therapeutic dose of DOX can activate ubiquitin-proteasome system. However, whether and how ubiquitin-proteasome system brings out DOX-induced card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yihui, Zhang, Hui, Ni, Yangyue, Wang, Xuejun, Chen, Yifan, Chen, Jiahui, Wang, Yan, Lin, Jinyi, Xu, Yuchen, Zhao, Jian-Yuan, Cheng, Leilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308790/ https://www.ncbi.nlm.nih.gov/pubmed/35871160 http://dx.doi.org/10.1038/s41419-022-05100-4

Ejemplares similares

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

MON-310 Oncogenic Roles of Tripartite Motif 25 in Endometrial Cancer
por: Horie-Inoue, Kuniko, et al.
Publicado: (2019)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
por: Hu, Xiaoliang, et al.
Publicado: (2022)

Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
por: Zhang, Wei, et al.
Publicado: (2023)

Evaluation of Ameliorative Effect of Quercetin and Candesartan in Doxorubicin-Induced Cardiotoxicity
por: Majhi, Sagarika, et al.
Publicado: (2022)

Tripartite motif 32 prevents pathological cardiac hypertrophy
por: Chen, Lijuan, et al.
Publicado: (2016)

The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
por: Mandell, Michael A., et al.
Publicado: (2020)

Peptide Szeto-Schiller 31 ameliorates doxorubicin-induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway
por: Zhang, Li, et al.
Publicado: (2021)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
por: Ono, Masaya, et al.
Publicado: (2022)

Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
por: Samir, Rania, et al.
Publicado: (2023)

Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity
por: Zhang, Guoxia, et al.
Publicado: (2022)

Nicorandil Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats, as Evaluated by 7 T Cardiovascular Magnetic Resonance Imaging
por: Wan, Yixuan, et al.
Publicado: (2021)

miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice
por: Li, Jun, et al.
Publicado: (2019)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model
por: Ahmad, Shafique, et al.
Publicado: (2017)

Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-Induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis
por: Wang, Lijiang, et al.
Publicado: (2019)

Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Tongmai Yangxin Pills in Ameliorating Doxorubicin-Induced Cardiotoxicity
por: Shu, Lexin, et al.
Publicado: (2023)

Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling
por: Sun, Nianfeng, et al.
Publicado: (2017)

Peptidomics Analysis Reveals Peptide PDCryab1 Inhibits Doxorubicin-Induced Cardiotoxicity
por: Zhang, Li, et al.
Publicado: (2020)

Tripartite motif 38 alleviates the pathological process of NAFLD–NASH by promoting TAB2 degradation
por: Yao, Xinxin, et al.
Publicado: (2023)

Regulation of Tripartite Motif-Containing Proteins on Immune Response and Viral Evasion
por: Zhang, Xiu-Zhong, et al.
Publicado: (2021)

GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
por: Wang, Yue, et al.
Publicado: (2018)

Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer
por: Wang, Dennis D., et al.
Publicado: (2021)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023)

Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions
por: Chen, Rirong, et al.
Publicado: (2022)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
por: Wang, Wei, et al.
Publicado: (2020)

The control of viral infection by tripartite motif proteins and cyclophilin A
por: Towers, Greg J
Publicado: (2007)

Tripartite Motif-Containing 29 Expression in Squamous Cell Carcinoma
por: Cho, Moon-Kyun
Publicado: (2012)

Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma
por: Han, Mingzhi, et al.
Publicado: (2021)

Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
por: Peng, Kezheng, et al.
Publicado: (2023)

Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro
por: Wang, Xiaoping, et al.
Publicado: (2021)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
por: Chen, Chih-Tai, et al.
Publicado: (2015)

Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
por: Wu, Yan-Zhao, et al.
Publicado: (2019)

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
por: Fan, Rui, et al.
Publicado: (2023)

Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1
por: Meng, Peina, et al.
Publicado: (2023)

Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
por: Yang, Hui, et al.
Publicado: (2020)

Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway
por: Lu, Guangping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fvjbvrvt21lam3jtn3g7u42bom